Clinical Trials Directory

Trials / Completed

CompletedNCT02509871

Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2)

Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Centre Jean Perrin · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This cross-sectional study of pathophysiology will bring additional informations on body composition of patients treated by adjuvant hormonal therapy for breast cancer. This is a complementary study of Metaca study (AU882).

Conditions

Interventions

TypeNameDescription
OTHERBody composition measurementDXA, impedance

Timeline

Start date
2015-07-01
Primary completion
2016-11-01
Completion
2016-11-01
First posted
2015-07-28
Last updated
2018-12-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02509871. Inclusion in this directory is not an endorsement.